Regular Review
Contraceptive -methods: risks and benefits
Despite the large amount of current research into new methods of fertility control,' British couples seeking reliable reversible contraception must still choose between the pill, the intrauterine device (IUD), and one of the occlusive methods. What do we know-about the risks and benefits of these different methods, and how can we use this information to counsel those seeking advice ?
Contraceptive pills containing a progestogen alone have never been widely used and accordingly have not been the subject of epidemiological investigation. They will not be considered further in this article, and the terms "the pill" and "oral contraceptives" will refer to combined preparations in what follows.
The well-established major adverse effects of oral contraceptives are principally on the cardiovascular system-deepvein thrombosis, pulmonary embolism, hypertension, stroke (both thrombotic and haemorrhagic), and acute myocardial infarction. In In general, occlusive methods of contraception are less effective than either the pill or the IUD, though highly motivated users may achieve remarkably good results. There is now reasonably firm evidence that use of the diaphragm (and, presumably, the -condom) offers some prctection from the risk of preinvasive carcinoma of the cervix,6 while wearing a condom certainly reduces the chance that a man will acquire gonorrhoea from his partner. 7 The suggestion that pressure of the rim of the diaphragm on the female urethra increases the risk of urinary tract infection remains to be confirmed. 8 Reasonably reliable information about the magnitude ofmost of the known hazards and benefits of the pill, the IUD, and occlusive methods of contraception is now available from two large British prospective studies, both of which started in 1968 and are still in progress. In the study by the Royal College of General Practitioners9 23 000 users of the pill aged 15-49 years together with a similar number of controls using other methods or no method of contraception were brought under observation by 1400 general practitioners. During follow-up doctors record the diagnoses of episodes of illness, oral contraceptive prescriptions, and information about pregnancies and deaths. In the Oxford University-Family Planning Association study,8 17 000 women aged 25-39 years using the pill, the diaphragm, or an IUD were recruited at one or other of 17 large family planning clinics. During follow-up information is collected about changes in contraceptive methods, pregnancies and their outcome, hospital attendances (outpatient and inpatient), deaths, and the results of cervical smears. From the two studies, morbidity data collected during about 150 000 woman-years of observation and mortality data collected during about 290 000 woman-years of observation have now been published. [8] [9] [10] [11] Vessey and Doll12 have used the morbidity data derived from these two studies to make comparisons between the different reversible methods of contraception. They used a very simple model, merely contrasting the experience of 100 000 women using the pill, 100 000 using an IUD, and 100 000 using a diaphragm, all of whom wanted to avoid pregnancy, during one year. Because the morbidity data obtained in the prospective studies had been published in the form of age-standardised rates, they were obliged to consider "women of child-bearing age" in their analysis. Looking first at non-obstetric morbidity, they concluded that the increased risk to oral contraceptive users of gallbladder disease and cervical erosion was roughly offset by the reduced risk of benign lesions of the breast and ovary and of menstrual disorders. Hence it seems fair to focus particular attention on the increased risk of cardiovascular disease and hepatocellular adenoma in pill users, and of major gynaecological disease in IUD users. In considering obstetric morbidity, Vessey and Doll pointed out that it was necessary to take into account both the efficacy of the different methods of contraception and the outcome of the unplanned pregnancies; accordingly, they produced a series of different estimates based on various sets of assumptions.
To provide some illustrative figures, let us assume that the failure rate experienced by women using the pill is 0-36 pregnancies per 100 woman-years (as observed in the RCGP study) and that the corresponding failure rates for users of the IUD and the diaphragm are 2 and 5 per 100 woman-years (these are reasonable representative figures for well-motivated women). Let us also assume that the outcome of unplanned pregnancies in users of different methods is as observed in the Oxford study, and that the cancelling-out of certain of the risks and benefits in pill users referred to in the last paragraph is valid. The 100 000 pill users would then have an excess of about 35 hospital admissions for stroke, 70 Similar calculations can be carried out on patterns of mortality. In addition, however, mortality data are available for different age groups. For women aged 20-34 years, the sum of the mortality attributable to the method and that attributable to accidental pregnancies is very low for each method of contraception (2-4 deaths per 100 000). For those aged 35-44 years, however, the pill compares unfavourably with the other methods: the approximate total attributable mortality per 100 000 for pill users is 20, for IUD users 2, and for diaphragm users also 2.
Simple analyses of the sort just described, while of value in providing crude comparisons between contraceptive methods, are subject to many limitations. Firstly, some of the morbidity estimates and all of the mortality estimates are based on small numbers of events and therefore subject to considerable sampling error. Secondly, restricting the analysis to counting deaths, hospital admissions, and obstetric events is very inadequate. To 
